Advertisement
Advertisement
U.S. markets close in 5 hours 53 minutes
Advertisement
Advertisement
Advertisement
Advertisement

American Funds 2060 Target Date Retirement Fund Class R-6 (RFUTX)

Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
14.30-0.01 (-0.07%)
As of 08:05AM EDT. Market open.
Advertisement
Full screen
Previous Close14.31
YTD Return-20.02%
Expense Ratio (net)0.00%
CategoryTarget-Date 2060+
Last Cap Gain0.00
Morningstar Rating★★★★
Morningstar Risk RatingBelow Average
Sustainability Rating
Net Assets5.19B
Beta (5Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last Dividend0.02
Average for CategoryN/A
Inception DateMar 27, 2015
  • GlobeNewswire

    Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022

    Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2022 financial results after the market close on Thursday, May 12, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update. DateThursday, May 12, 2022Time4:30 p.m. ETW

Advertisement
Advertisement